AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35465764 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple opt-in message
Number of subjects: 610
Study 35465764 — intervention group
Group type: COMPARATOR
Intervention: Recommendation by the hospital
Number of subjects: 610
Study 35465764 — intervention group
Group type: COMPARATOR
Intervention: Community-oriented message
Number of subjects: 610
Study 35465764 — intervention group
Group type: COMPARATOR
Intervention: Acknowledgment of vaccine hesitancy
Number of subjects: 610
Study 35465764 — intervention group
Group type: COMPARATOR
Intervention: Overall willingness to accept vaccination in the ED
Number of subjects: 610
Study 32522422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit & Strong! Program (8-week multicomponent program)
Number of subjects: 31
Study 32522422 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study 32054426 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental scaling and root planing (SRP) for 6 months
Number of subjects: 10
Study 32054426 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 10
Study 35432165 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 36
Study 35432165 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 36
Study 35432165 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 36
Study 32539426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-assisted anesthesia (AAA) with electrostimulation (2-4 Hz) at LI4 and PC6, and additional stimulation at the lump site (30 Hz)
Number of subjects: 17
Study 33125753 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR247799 1 mg
Number of subjects: 54
Study 33125753 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR247799 5 mg
Number of subjects: 54
Study 33125753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg (positive control)
Number of subjects: 54
Study 33125753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance from urban edge (0 m, 50 m, 100 m, 500 m)
Number of subjects: 1172
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized Difference Vegetation Index (NDVI) (low, medium, high)
Number of subjects: 1172
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Morisita overlap index
Number of subjects: 1172
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Aedes albopictus and Ae. aegypti
Number of subjects: 1172
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest specialists (Haemagogus janthinomys, Sabethes glaucodaemon, Sa. tridentatus)
Number of subjects: 1172
Study 32173316 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichoprosopon digitatum and Psorophora amazonica
Number of subjects: 1172
Study 34299814 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 307
Study 33257343 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide (10 mg orally)
Number of subjects: 236
Study 33257343 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (15 mg/kg orally, max 975 mg)
Number of subjects: 236
Study 33257343 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide
Number of subjects: 236
Study 33257343 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 236
Study 36229087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) lowering
Number of subjects: 8820
Study 36229087 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure (SBP) lowering
Number of subjects: 8820
Study 32994374 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma Assessment Tool for Family Caregivers of People with Mental Illness (SAT-FAM)
Number of subjects: 286
Study 35274750 — intervention group
Group type: EXPERIMENTAL
Intervention: Function Focused Care for Acute Care (FFC-AC)
Number of subjects: 0
Study 35274750 — intervention group
Group type: EXPERIMENTAL
Intervention: FFC-AC-EIT (Function Focused Care integrated with Evidence Integration Triangle)
Number of subjects: 0
Study 33794131 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized postextubation respiratory support (noninvasive ventilation for suspected hypercapnia, high-flow nasal cannula for others)
Number of subjects: 751
Study 33794131 — intervention group
Group type: COMPARATOR
Intervention: Usual care (postextubation management at the discretion of treating clinicians)
Number of subjects: 751
Study 35878575 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR)
Number of subjects: 55
Study 35878575 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta-1a (IFNb-1a)
Number of subjects: 55
Study 35878575 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 55
Study 36309690 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted gluteal intervention
Number of subjects: 27
Study 36309690 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 27
Study 34020931 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus docetaxel (75 mg/m2 q3w for ten cycles)
Number of subjects: 413
Study 34020931 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 413
Study 34020931 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus docetaxel
Number of subjects: 413
Study 32268604 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 55
Study 32268604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 34391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr)
Number of subjects: 604
Study 34391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in KCCQ-OS from baseline to 1 month
Number of subjects: 604
Study 34391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in 6MWD from baseline to 1 month
Number of subjects: 604
Study 34391740 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline 6MWD
Number of subjects: 604
Study 36109453 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 70
Study 36109453 — intervention group
Group type: COMPARATOR
Intervention: 0.5% ropivacaine
Number of subjects: 70
Study 33146791 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated model using clinical, CT, PET/CT, and histopathological features
Number of subjects: 399
Study 33146791 — intervention group
Group type: COMPARATOR
Intervention: Histopathological features
Number of subjects: 399
Study 33146791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram with clinical, imaging, and histopathological features
Number of subjects: 399
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressured sexting
Number of subjects: 2199
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving unsolicited sexts
Number of subjects: 2199
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Forwarding sexts without permission
Number of subjects: 2199
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking someone for sexts
Number of subjects: 2199
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Being asked to send a sext
Number of subjects: 2199
Study 33803243 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensual sexting
Number of subjects: 2199
Study 35708743 — intervention group
Group type: EXPERIMENTAL
Intervention: Web- and smartphone-based PA program
Number of subjects: 228
Study 35708743 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual PA advice)
Number of subjects: 228
Study 33962517 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Plus intervention
Number of subjects: 585
Study 32392455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 20-80 mg
Number of subjects: 0
Study 32392455 — intervention group
Group type: COMPARATOR
Intervention: Lurasidone
Number of subjects: 0
Study 35819570 — intervention group
Group type: EXPERIMENTAL
Intervention: macitentan 10 mg
Number of subjects: 742
Study 34581194 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 4077
Study 34581194 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 4077
Study 95358022 — intervention group
Group type: EXPERIMENTAL
Intervention: S + preS2 vaccine
Number of subjects: 0
Study 95358022 — intervention group
Group type: EXPERIMENTAL
Intervention: S vaccine
Number of subjects: 0
Study 95358022 — intervention group
Group type: COMPARATOR
Intervention: Any vaccine used
Number of subjects: 0
Study 34889883 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection Cerebrolysin 5 mL diluted in 100 mL Normal Saline over 30 minutes once a day for 21 days postoperatively
Number of subjects: 60
Study 34889883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34969632 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus bevacizumab
Number of subjects: 153
Study 34969632 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine plus bevacizumab
Number of subjects: 153
Study 33883195 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal-bolus insulin (BBI) regimen
Number of subjects: 305
Study 33883195 — intervention group
Group type: COMPARATOR
Intervention: Fixed ratio of basal insulin plus GLP-1RA (fixed-combo group)
Number of subjects: 305
Study 33883195 — intervention group
Group type: COMPARATOR
Intervention: Basal insulin plus SGLT2 inhibitor (gliflo-combo group)
Number of subjects: 305
Study 33734144 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Thoracic Paravertebral Block (TPVB)
Number of subjects: 90
Study 33734144 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Pectoral Nerve Block (PEC)
Number of subjects: 90
Study 33734144 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Opioid Analgesia (PCA-M)
Number of subjects: 90
Study 33137422 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound (10 sessions over two weeks, continuous ultrasound at an intensity of 0.7 to 0.8 w/cm2, frequency of 3 MHz for 5 minutes) plus standard care (n = 16)
Number of subjects: 31
Study 33137422 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (n = 15)
Number of subjects: 31
Study 32037263 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week hospital based physical therapy (intervention group, n=8)
Number of subjects: 15
Study 33544066 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 62
Study 33544066 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 62
Study 32636128 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1800 mg/day
Number of subjects: 60
Study 32636128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 32694482 — intervention group
Group type: EXPERIMENTAL
Intervention: REBUS-guided TBC
Number of subjects: 10
Study 32694482 — intervention group
Group type: COMPARATOR
Intervention: Non-REBUS TBC
Number of subjects: 10
Study 32453406 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal plus preventive treatment
Number of subjects: 120
Study 32453406 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive treatment without withdrawal
Number of subjects: 120
Study 32453406 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal with optional preventive treatment 2 months after withdrawal
Number of subjects: 120
Study 34186112 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone after cardiac surgery
Number of subjects: 0
Study 34186112 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Ventricle Reconstruction trial
Number of subjects: 0
Study 32294074 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who previously underwent cosmetic procedures
Number of subjects: 40
Study 32294074 — intervention group
Group type: COMPARATOR
Intervention: Control group (women without a history of cosmetic procedures)
Number of subjects: 40
Study 35483576 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support tools (DSTs) including online patient decision aids, consultation cards, and decision cards; training on how to apply shared decision making (SDM) during clinician-patient encounters
Number of subjects: 342
Study 35483576 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support tools (DSTs)
Number of subjects: 342
Study 35483576 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM training for surgeons
Number of subjects: 342
Study 35483576 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid for patients
Number of subjects: 342
Study 36942420 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of exercise and liraglutide 3.0 mg/d
Number of subjects: 195
Study 36942420 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg/d
Number of subjects: 195
Study 36942420 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 195
Study 36942420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 32342247 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative GL group receiving 100 mL of 5% glucose solution immediately after local anesthesia
Number of subjects: 54
Study 32342247 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative GL group receiving 100 mL of 5% glucose solution immediately after surgery completion
Number of subjects: 54
Study 32342247 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving glucose-free sodium lactate Ringer's solution
Number of subjects: 54
Study 32342247 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic and diastolic blood pressure and heart rate
Number of subjects: 54
Study 35453088 — intervention group
Group type: EXPERIMENTAL
Intervention: MPS Ion AmpliSeq™ HID Y‐SNP Research Panel v1
Number of subjects: 182
Study 34080920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (15 mg at bedtime)
Number of subjects: 10
Study 34080920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33036063 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported longer estimate
Number of subjects: 354
Study 33036063 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-reported longer estimate
Number of subjects: 354
Study 33036063 — intervention group
Group type: COMPARATOR
Intervention: Patients screening positive for polypharmacy
Number of subjects: 354
Study 33036063 — intervention group
Group type: COMPARATOR
Intervention: Caregivers reporting greater distress
Number of subjects: 354
Study 33036063 — intervention group
Group type: COMPARATOR
Intervention: Caregivers when patients screened positive for polypharmacy
Number of subjects: 354
Study 33036063 — intervention group
Group type: COMPARATOR
Intervention: Caregivers when patients had lower perceived self-efficacy in interacting with physicians
Number of subjects: 354
Study 34187758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT) protocol for 12 weeks
Number of subjects: 77
Study 34187758 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study 35775129 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous integrated boost (SIB) protocol with 4.45 Gy dose increase
Number of subjects: 57
Study 35775129 — intervention group
Group type: COMPARATOR
Intervention: Control protocol (10 × 4 Gy)
Number of subjects: 57
Study 33779991 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training (n = 24)
Number of subjects: 34
Study 33779991 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity training (n = 23)
Number of subjects: 34
Study 33334330 — intervention group
Group type: EXPERIMENTAL
Intervention: Fertility educational program (verbal and virtual educational package at five time episodes within 4 weeks)
Number of subjects: 1240
Study 33334330 — intervention group
Group type: COMPARATOR
Intervention: Typical premarital counselling training
Number of subjects: 1240
Study 36353530 — intervention group
Group type: EXPERIMENTAL
Intervention: TOLF intervention group
Number of subjects: 92
Study 36353530 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 33541062 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum treatment for molar distalization over 6 months
Number of subjects: 12
Study 33541062 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum treatment for molar distalization
Number of subjects: 12
Study 33541062 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment) after one year
Number of subjects: 12
Study 32865062 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-125 seed interstitial brachytherapy
Number of subjects: 165
Study 32865062 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy perfusion
Number of subjects: 165
Study 33626028 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hypotension (POH) defined as a single measurement of mean arterial pressure (MAP) below thresholds of ≤75 mm Hg, ≤65 mm Hg, and ≤55 mm Hg.
Number of subjects: 67968
Study 33626028 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hypotension (POH) defined as a single measurement of MAP below thresholds of ≤75 mm Hg, ≤65 mm Hg, and ≤55 mm Hg.
Number of subjects: 67968
Study 35754130 — intervention group
Group type: EXPERIMENTAL
Intervention: extensively hydrolyzed whey-protein formula (eHWF)
Number of subjects: 34
Study 32863246 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-guided coronary stent implantation
Number of subjects: 2490
Study 32863246 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided coronary stent implantation
Number of subjects: 2490
Study 36154947 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhancing Contact Model (ECM)
Number of subjects: 253
Study 36154947 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational Family Intervention (PFI)
Number of subjects: 253
Study 36154947 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 253
Study 34433843 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-hybrid composite restorations (Group Am, n=44)
Number of subjects: 124
Study 34433843 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-ceramic composite restorations (Group An, n=42)
Number of subjects: 124
Study 32396592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice drink (375 mg total flavan‐3‐ols)
Number of subjects: 10
Study 32396592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice drink (716 mg total flavan‐3‐ols)
Number of subjects: 10
Study 32396592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice drink (1131 mg total flavan‐3‐ols)
Number of subjects: 10
Study 32396592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice drink (1396 mg total flavan‐3‐ols)
Number of subjects: 10
Study 32396592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice drink (1741 mg total flavan‐3‐ols)
Number of subjects: 10
Study 32396592 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control drink
Number of subjects: 10
Study 33805346 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urea level
Number of subjects: 13430
Study 32378071 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified FOLFOX6 (oxaliplatin in combination with 5‐fluorouracil and l‐leucovorin)
Number of subjects: 35
Study 32102813 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 54
Study 32102813 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 54
Study 36412341 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri UBLRU‐87
Number of subjects: 60
Study 36412341 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum UBBB‐55
Number of subjects: 60
Study 36412341 — intervention group
Group type: EXPERIMENTAL
Intervention: Blend of Lactobacillus reuteri and Bifidobacterium bifidum
Number of subjects: 60
Study 36412341 — intervention group
Group type: COMPARATOR
Intervention: Control group (curd with no probiotic)
Number of subjects: 60
Study 33415858 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (round magnetic needle tapping plus acupuncture at Qi Shen Zhen)
Number of subjects: 57
Study 33415858 — intervention group
Group type: COMPARATOR
Intervention: Medication group (Escitalopram Oxalate tablets 5-20 mg/d)
Number of subjects: 57
Study 34696941 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive format (fact box)
Number of subjects: 300
Study 34696941 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated experience format (interactive simulation)
Number of subjects: 300
Study 34696941 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 300
Study 33403921 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-focused, digital meditation training
Number of subjects: 0
Study 33250205 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily)
Number of subjects: 64
Study 33250205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34219669 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-consistent PCI
Number of subjects: 1391
Study 34219669 — intervention group
Group type: COMPARATOR
Intervention: QFR-inconsistent PCI
Number of subjects: 1391
Study 34219669 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-consistent PCI (adjusted)
Number of subjects: 1391
Study 34219669 — intervention group
Group type: COMPARATOR
Intervention: QFR-inconsistent PCI (adjusted)
Number of subjects: 1391
Study 34219669 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-consistent PCI (ischaemia-driven revascularisation)
Number of subjects: 1391
Study 34219669 — intervention group
Group type: COMPARATOR
Intervention: QFR-inconsistent PCI (ischaemia-driven revascularisation)
Number of subjects: 1391
Study 34836079 — intervention group
Group type: EXPERIMENTAL
Intervention: EX (exercise routine only)
Number of subjects: 0
Study 34836079 — intervention group
Group type: EXPERIMENTAL
Intervention: EXDC (exercise + dietary counseling)
Number of subjects: 0